AnalystsPaul ChoiPaul Choi's Stock Forecasts
AnalystsPaul Choi
Analyst Ranking
Top 28%
#1431 out of 5157 analysts
Average Return
+2.87%
Win Rate
45%36 out of 80
Risk vs Reward
Poor
Good
Paul Choi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gossamer Bio IncGOSS | +308.07% | $0.84 | $3.44 | 2025-04-16 - 2025-12-19 | Strong Buy |
Gossamer Bio IncGOSS | +230.77% | $1.04 | $3.44 | 2025-05-15 - 2025-12-19 | Strong Buy |
Pandion Therapeutics IncPAND | +218.57% | $18.85 | $60.05 | 2020-08-10 - 2021-03-31 | Strong Buy |
Tesaro IncTSRO | +177.42% | $27.02 | $74.96 | 2018-08-05 - 2019-01-18 | Strong Buy |
Gossamer Bio IncGOSS | +146.15% | $0.52 | $1.28 | 2024-06-16 - 2025-06-16 | Strong Buy |
Paul Choi Analyst Color
Get additional color on Paul Choi's coverage of popular stocks
Paul Choi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vera Therapeutics IncVERA | 1 | Strong Buy | $95.00 | +85.47% | Maintains | 3 days ago |
Cytokinetics IncCYTK | 3 | Strong Buy | $95.00 | +51.47% | Upgrades | 3 days ago |
Ptc Therapeutics IncPTCT | 8 | Strong Sell | $50.00 | -36.36% | Maintains | 2 months ago |
Bridgebio Pharma IncBBIO | 4 | Strong Buy | $100.00 | +31.06% | Maintains | 2 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 2 | Strong Buy | $55.00 | +27.34% | Maintains | 2 months ago |
Arvinas IncARVN | 4 | Strong Sell | $6.00 | -48.63% | Downgrades | 2 months ago |
Lantheus Holdings IncLNTH | 2 | Hold | $77.00 | +16.81% | Downgrades | 2 months ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $20.00 | -21.72% | Initiates Coverage On | 3 months ago |
Exelixis IncEXEL | 1 | Strong Buy | $47.00 | +6.09% | Initiates Coverage On | 3 months ago |
Amarin Corp PLCAMRN | 9 | Strong Sell | $12.00 | -13.04% | Maintains | 6 months ago |
Urogen Pharma LtdURGN | 4 | Hold | $3.00 | -86.84% | Maintains | 7 months ago |
Gossamer Bio IncGOSS | 6 | Strong Buy | $8.00 | +132.56% | Maintains | 7 months ago |
Phathom Pharmaceuticals IncPHAT | 8 | Hold | $5.00 | -71.48% | Maintains | 8 months ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $52.00 | +17.91% | Maintains | 8 months ago |
Vir Biotechnology IncVIR | 7 | Strong Buy | $21.00 | +264.58% | Maintains | 8 months ago |
Regenxbio IncRGNX | 3 | Hold | $12.00 | -17.75% | Maintains | 8 months ago |
Esperion Therapeutics IncESPR | 3 | Hold | $3.00 | -23.66% | Maintains | 8 months ago |
Dynavax Technologies CorpDVAX | 4 | Strong Sell | $10.00 | -7.92% | Maintains | 8 months ago |
Ascendis Pharma AASND | 4 | Strong Buy | $225.00 | +12.51% | Maintains | 10 months ago |
Hutchmed LtdHCM | 6 | Hold | $19.00 | N/A | Maintains | a year ago |
Foghorn Therapeutics IncFHTX | 2 | Strong Buy | $19.00 | N/A | Maintains | 2 years ago |
Fibrogen IncFGEN | 7 | Strong Sell | $50.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 2 | Strong Buy | $26.00 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Hold | $4.00 | N/A | Downgrades | 3 years ago |
Ars Pharmaceuticals IncSPRY | 1 | Hold | $3.50 | N/A | Downgrades | 4 years ago |
Allakos IncALLK | 2 | Hold | $60.00 | N/A | Maintains | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Strong Buy | $170.00 | N/A | Maintains | 4 years ago |
Axcella Health IncAXLA | 2 | Hold | $125.00 | N/A | Downgrades | 4 years ago |
Korro Bio IncKRRO | 1 | Hold | $9.00 | N/A | Downgrades | 4 years ago |
Pmv Pharmaceuticals IncPMVP | 2 | Strong Buy | $43.00 | N/A | Upgrades | 4 years ago |
Puma Biotechnology IncPBYI | 4 | Strong Sell | $8.00 | N/A | Maintains | 4 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $132.00 | N/A | Assumes | 5 years ago |
Radius Health IncRDUS1 | 1 | Strong Buy | $33.00 | N/A | Assumes | 5 years ago |
Springworks Therapeutics IncSWTX | 1 | Strong Buy | $112.00 | N/A | Assumes | 5 years ago |
Myovant Sciences LtdMYOV | 1 | Hold | $30.00 | N/A | Downgrades | 5 years ago |
Pandion Therapeutics IncPAND | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Viela Bio IncVIE | 3 | Hold | $49.00 | N/A | Upgrades | 5 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $103.00 | N/A | Upgrades | 5 years ago |
Neurocrine Biosciences IncNBIX | 1 | Hold | $135.00 | N/A | Downgrades | 5 years ago |
Dianthus Therapeutics IncDNTH | 1 | Strong Buy | $15.00 | N/A | Upgrades | 6 years ago |
Immunomedics IncIMMU | 2 | Hold | $22.00 | N/A | Upgrades | 6 years ago |
Nektar TherapeuticsNKTR | 2 | Hold | $300.00 | N/A | Upgrades | 6 years ago |
Clovis Oncology IncCLVSQ | 3 | Strong Buy | $40.00 | N/A | Maintains | 7 years ago |
Tesaro IncTSRO | 3 | Strong Buy | $56.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.